Divergent trial results on cancer vaccines have the field grappling with hard questions The approach, and the use of mRNA, is still exciting researchers, though much remains unknown

Divergent trial results on cancer vaccines have the field grappling with hard questions The approach, and the use of mRNA, is still exciting researchers, though much remains unknown https://www.statnews.com/2026/10/05/cancer-vaccines-mrna-clinical-trials/ By Allison DeAngelisOct. 5, 2026 Biotech Startups and Venture Capital Reporter